Elanco Animal Health Incorporated Common Stock

ELAN · Pharmaceutical Preparations · $11.2B
Falling back
ELAN
$22.42
▼ −1.41%
09/18 O 22.77 H 22.88 L 22.27 C 22.42 ▼ −1.41%
Vol 7.9M RS 36
RS rating36
Now vs pivot (%)−5.40%
Tightening (ATR ratio)1.34×
Volume dry-up1.00×
Up/down volume, net-0.13
From 52-week high20%
failed pokeplayed out
Falling back
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 5.2 weeks and fell 14% from its ceiling at its deepest. The pivot is $23.70, and the stock closed 5.4% below it. Its relative strength rating is 36.

Also on
Peers
Catalyst roadmap
  1. EarningstentativeLLY · competitorin 41d
    LLY reports
    Oct 29, 2026
  2. Earningstentativein 49d
    Quarterly earnings
    Nov 6, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
Elanco Director Purchases 40,000 Shares for $936,000The Motley Fool · 2026-09-04

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Elanco Animal Health Incorporated Common Stock (ELAN) — The Tape